Recent Contributions

Subscrive to our RSS feed

Screenshot Date Categories Title Author Format
Clinical management of CVD risk in abdominal obesity and type 2 diabetes targeting blood pressure February 03, 2012 Clinical management of CVD risk in abdominal obesity and type 2 diabetes targeting blood pressure Paul Poirier, MD, PhD, FRCPC, FACC, FAHA, Associate Professor, Faculty of Pharmacy, Université Laval, Québec City, Quebec, Canada Slide Library
43 slides
2 MB
Has there been any significant advances made in our understanding of nutritional factors modulating insulin resistance and inflammation? February 01, 2012 Has there been any significant advances made in our understanding of nutritional factors modulating insulin resistance and inflammation? André Marette, PhD, Department of Medicine, Université Laval, Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec, Québec, QC, Canada Expert Opinions
Video 1:24 min.
6 MB
Could you describe the key regional differences in adipose tissue morphology and metabolism? January 25, 2012 Could you describe the key regional differences in adipose tissue morphology and metabolism? André Tchernof, PhD, Department of Nutrition, Université Laval, Endocrinology and Genomics axis, Laval University Medical Centre, Québec, QC, Canada Expert Opinions
Video 1:44 min.
8 MB
How do you see the future of assessment and management of valve diseases? January 18, 2012 How do you see the future of assessment and management of valve diseases? Patrick Mathieu, MD, Department of Surgery, Université Laval, Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec, Québec, QC, Canada Expert Opinions
Video 2:15 min.
10 MB
Could you  tell us more about the history and rationale of the Dallas Heart Study? January 11, 2012 Could you tell us more about the history and rationale of the Dallas Heart Study? Gloria Lena Vega, PhD, The Metabolic Unit, Lipid, and Diabetes Clinics of the Veterans Affairs North Health Care System, Dallas, TX, USA Expert Opinions
Video 1:29 min.
7 MB
In your epidemiological studies, which key nutritional factors have you identified in the risk of cardiovascular disease and type 2 diabetes? January 04, 2012 In your epidemiological studies, which key nutritional factors have you identified in the risk of cardiovascular disease and type 2 diabetes? Frank Hu, MD, PhD, Departments of Nutrition and Epidemiology, Harvard School of Public Health, Boston, MA, USA Expert Opinions
Video 1:48 min.
8 MB
What are the key therapeutic targets to optimally reduce cardiovascular disease risk in patients with type 2 diabetes? December 28, 2011 What are the key therapeutic targets to optimally reduce cardiovascular disease risk in patients with type 2 diabetes? Darren McGuire, MD, MHSC, Division of Cardiology and Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA Expert Opinions
Video 0:37 min.
2 MB
Could you describe the situation in Mexico regarding the evolving prevalence of abdominal obesity and metabolic syndrome? December 21, 2011 Could you describe the situation in Mexico regarding the evolving prevalence of abdominal obesity and metabolic syndrome? Carlos A. Aguilar-Salinas, MD, Department of Endocrinology and Metabolism, Instituto Nacional de Ciencias Médicas y Nutrición, Salvador Zubiran (INCMNSZ), Mexico City, Mexico Expert Opinions
Video 1:08 min.
5 MB
Which emergent economies are mostly afflicted by an overconsumption of sugar-sweetened beverages? December 14, 2011 Which emergent economies are mostly afflicted by an overconsumption of sugar-sweetened beverages? Barry Popkin, PhD, Department of Nutrition, School of Public Health and Medicine Department of Economics, The University of North Carolina at Chapel Hill, NC, USA Expert Opinions
Video 1:16 min.
5 MB
How is this International Congress on Abdominal Obesity different from other international medical meetings? December 07, 2011 How is this International Congress on Abdominal Obesity different from other international medical meetings? Walmir Coutinho, MD, Professor of Endocrinology, Pontifical Catholic University of Rio de Janeiro, Rio de Janeiro, Brazil Expert Opinions
Video 0:34 min.
2 MB
Could you comment on the evolution of the International Chair on Cardiometabolic Risk since it was launched 5 years ago? November 30, 2011 Could you comment on the evolution of the International Chair on Cardiometabolic Risk since it was launched 5 years ago? Peter Libby, MD, Chief, Cardiovascular Medicine, Brigham and Women's Hospital, Mallinckrodt Professor of Medicine, Harvard Medical School, Boston, USA Expert Opinions
Video 1:28 min.
7 MB
What are potentially interesting new tools to better assess physical activity both in large epidemiological studies as well as in clinical pratice?
November 23, 2011 What are potentially interesting new tools to better assess physical activity both in large epidemiological studies as well as in clinical pratice? Nicholas J. Wareham, MB, PhD, Director, MRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge, Cambridge, UK Expert Opinions
Video 1:27 min.
7 MB
What is the relationship of visceral adiposity and liver fat to cardiometabolic risk? November 16, 2011 What is the relationship of visceral adiposity and liver fat to cardiometabolic risk? Jean-Pierre Després, PhD, FAHA, FIAS, Scientific Director, International Chair on Cardiometabolic Risk, Professor, Division of Kinesiology, Université Laval, Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec, Québec, QC, Canada Expert Opinions
Video 1:10 min.
5 MB
Why are HDL cholesterol levels low among individuals with abdominal obesity and with features of the metabolic syndrome? November 09, 2011 Why are HDL cholesterol levels low among individuals with abdominal obesity and with features of the metabolic syndrome? H. Bryan Brewer, Jr., MD, Director, Washington Cardiovascular Associates, Senior Research Consultant, Cardiovascular Research Institute, Washington Hospital Center, Washington, D.C., USA Expert Opinions
Video 0:41 min.
3 MB
Health benefits of substituting water for sugar-sweetened beverages November 08, 2011 Health benefits of substituting water for sugar-sweetened beverages The International Chair on Cardiometabolic Risk Webcasts
Video 3:42 min.
17 MB